| Issue Date | Title | Author(s) | Relation | scopus | WOS | Fulltext/Archive link |
| 2009 | Higher prevalence of secretory CSE1L/CAS in sera of patients with metastatic cancer. | Tung, MC; Tsai, CS; Tung, JN; Tsao, TY; Chen, HC; Yeh, KT; Liao, CF; Jiang, MC | CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION 18(5), 1570-1577 | | | |
| 2021 | Proteomics-based identification of TMED9 is linked to vascular invasion and poor prognoses in patients with hepatocellular carcinoma | Yang, YC; Chien, MH; Lai, TC; Tung, MC; Jan, YH; Chang, WM; Jung, SM; Chen, MH; Yeh, CN; Hsiao, M | JOURNAL OF BIOMEDICAL SCIENCE 28, 29 | | | |
| 2020 | Stabilization of ADAM9 by N-α-acetyltransferase 10 protein contributes to promoting progression of androgen-independent prostate cancer | Lin, YW; Wen, YC; Chu, CY; Tung, MC; Yang, YC; Hua, KT; Pan, KF; Hsiao, M ; Lee, WJ; Chien, MH | Cell Death & Disease 11, 591 | | | |
| 2022 | Targeting DRD2 by the Antipsychotic Drug, Penfluridol, Retards Growth of Renal Cell Carcinoma via Inducing Stemness Inhibition and Autophagy-mediated Apoptosis | Tung, MC; Lin, YW; Lee, WeJ; Wen, YC; Liu, YC; Chen, JQ; Hsiao, M ; Yang, YC; Chien, MH | CELL DEATH & DISEASE 13(4), 400 | | | |
